Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: billkirn who wrote (3750)	2/6/1998 2:24:00 AM
From: Joe E.	Read Replies (3) \| Respond to of 6136

Re buffalo hump etc. fat accumulations. I thought these were associated solely with Crix. Is his true??

To: billkirn who wrote (3750)	2/6/1998 10:14:00 AM
From: Oliver & Co	Read Replies (2) \| Respond to of 6136

Not significant. Besides, is there a better treatment for this deadly disease yet? We know very well that complications will happen with treatment. Probably, as I have stated previously, the greatest question is, what will happen to patients on whom the P450 Cyt is blocked for extended periods (maybe as long as 10 years) Bottom line, until PIs came along, and were used in combo Rx, the death rate did not drop. So, what is better, more fat, or dying?